Study Details

Healthy Adults, Age 18-65

Study Number

8409-184- G4

Group

Group 2

Gender

both

Age

18-65

Location

Madison, Wisconsin

Compensation

$7,658

Study Dates

Jan. 06 - May 12, 2020

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

•Healthy Non-Smoking Adults age 18-65

•BMI (body mass index) 18-30

•Join us for a stay of 8 nights followed by 11 outpatient visits

•Compensation up to $7658 may be provided for time and participation

Details

Screening Dates: Dec 10, 11, 12, 13, 16, 17, 18, 19, 30, 31

Check-In: Jan 6
Check-Out: Jan 14

Outpatient Visits:
Jan 17, 21, 28
Feb 4, 18
Mar 3, 17
Apr 14, 28
May 12

Study Number

8409-184- G4

Group

Group 2

Gender

both

Age

18-65

Location

Madison, Wisconsin

Compensation

$7,658

Study Dates

Jan. 06 - May 12, 2020

Additional Information

This is a research study for Denosumab, a commercially available drug marketed as Prolia® or Xgeva® and used to treat conditions of the bones, such as osteoporosis and the prevention of skeletal-related events in solid tumors. The purpose of this study is to compare the blood levels of the approved formulation to an investigational formulation.

•Healthy Non-Smoking Adults age 18-65

•BMI (body mass index) 18-30

•Join us for a stay of 8 nights followed by 11 outpatient visits

•Compensation up to $7658 may be provided for time and participation

Details

Screening Dates: Dec 10, 11, 12, 13, 16, 17, 18, 19, 30, 31

Check-In: Jan 6
Check-Out: Jan 14

Outpatient Visits:
Jan 17, 21, 28
Feb 4, 18
Mar 3, 17
Apr 14, 28
May 12

Calculate Your BMI!

Calculate Your BMI!